Background and Aims: It has been known that the cell count and fraction of bronchoalveolar lavage fluid: BALF specimen is useful to diagnose as interstitial lung disease including sarcoidosis. We have a hypothesis that alveolar macrophage: AM on BALF in sarcoidosis has the characteristic cell form because sarcoidosis is disease constitute granuloma due to epithelial cells.
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Aim of this study is to determine the characteristic cell form of AM in sarcoidosis.
Methods: Fifteen cases of sarcoidosis were enrolled in this study.
We analyzed the cell area, nuclear area, and NC ratio of AM on BALF specimen by digital microscope. Primary endpoint was a comparison of those findings in between sarcoidosis and healthy volunteer (n = 5). Also, we compared with those in pulmonary alveolar proteinosis: PAP (n = 10). Secondary endpoints were to investigate the following findings of AM on BALF in sarcoidosis: deviation of nuclear, chromatin hyperplasy of nuclear, phagosome, and ruffling.
Results: Median cell area and nuclear area of AM in sarcoidosis was 335 and 90 μm 2 , respectively. These findings were significant larger than those of healthy volunteer (90 and 26 μm 2 , respectively). They were as same as those of PAP (315 and 53 μm 2 , respectively). Although NC ratio of AM in sarcoidosis was as same as those of healthy volunteer, they were larger than those of PAP. Also, the following findings: chromatin hyperplasy of nuclear, phagosome, and ruffling were associated with the growth of cell size.
Conclusion: AM form in sarcoidosis was clearly difference from healthy volunteer. As compared with healthy volunteer, both cell area and nuclear area of AM increased in sarcoidosis. It suggested the above findings were caused by the increase of bubble appearance in nuclear and cytoplasm. Also, it is interesting the large AM tends to have the ruffling of cell surface. This result might be important finding to evaluate the activity in sarcoidosis in the future. Background and Aims: We hypothesized that AngII stimulated macrophages-released exosomes containing AT1R promoted collagen production and pulmonary fibrosis via activating AngII/AT1R axis.
Methods: In vivo, we established three animal models. The first model was treated with BLM and then was sacrificed at Day3, Day7, Day14, Day28, respectively. The second model was treated with GW4869, an exosomes inhibitor, after receiving BLM; The third model was treated with irbesartan, an AT1R inhibitor, along with exosomes injection once a week. In vitro, fibroblasts were pretreated with irbesartan before exposure to exosomes or AngII.
Results: In vivo, Macrophages were significantly increased in lung tissue and BALF during pulmonary fibrosis. GW4869 markedly attenuated BLM-induced pulmonary fibrosis with decreased AngII/AT1R levels.
Exosomes promoted pulmonary fibrosis along with AngII/AT1R axis activation, which can be reversed by irbesartan. In vitro, AT1R containing exosomes-derived from macrophages treated with AngII activated TGF-b/ Smad2/3 pathway and stimulated collagen product via upregulating AngII/ AT1R axis. In turn, the increased AngII promoted the secretion of macrophage exosomes. is the standard treatment for obstructive sleep apnea (OSA) and mandibular advancement device (MAD) is an alternative. Recently, 4 studies showed the CPAP pressure could predict the MAD effect on reduction of apneahypopnea index (AHI). However, the cutoff of CPAP pressure, participants races and prior CPAP treatment was inconsistent across studies. Hence, this study aimed to investigate the association between CPAP pressure and the MAD effect in Taiwanese OSA patients who were treatment-naïve.
Methods: This retrospective study was conducted by reviewing medical records. Adult patients with OSA (AHI ≥ 10/h), who were treatmentnaïve and underwent CPAP titration were eligible. Those who refused CPAP treatment and were treated with 12-week MAD were recruited. Success of MAD treatment was classified according to 3 definitions, namely criteria 1 (residual AHI < 5/h with >50% reduction), criteria 2 (residual AHI < 10/h with >50% reduction) and criteria 3 (reduction > 50%). The logistic regression analysis was applied to identify the association between the CPAP pressure and success of MAD treatment. 
Conclusion:
The CPAP pressure < 15 cmH2O was associated with AHI reduction >50% with MAD treatment in Taiwanese treatment-naïve OSA patients.
